Thomas J. Schall, Director at Immuneering Corp (IMRX), bought 21,645 shares at $4.67 ($101K) on 2026-01-15, disclosed to the SEC on 2026-01-20.
Open-market purchase of $101k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |
| CCXI | SELL | 2020-12-16 | $3.7M | — | Filing → |